1. Catalogs
  2. PHC Europe
  3. ATHFAST™ PRESEPSIN – The Sepsis Biomarker Brochure

ATHFAST™ PRESEPSIN – The Sepsis Biomarker Brochure

ATHFAST™  PRESEPSIN – The Sepsis Biomarker Brochure
1 / 27 PagesView full catalog

ATHFAST™ PRESEPSIN – The Sepsis Biomarker Brochure

Product catalog summary
Sepsis Overview: Sepsis is a significant global health issue, affecting over 30 million people annually and causing approximately 6 million deaths. It is especially prevalent in low- and middle-income countries and is the leading cause of hospital readmissions in the U.S., with an annual cost exceeding $24 billion. Sepsis arises from an overwhelming immune response to infection, leading to widespread inflammation, blood clots, and impaired blood flow, which can result in organ damage.
Sepsis Definitions and Diagnosis: The definition of sepsis has evolved, with Sepsis-3 being the most recent, utilizing the SOFA score to assess organ dysfunction severity. Quick SOFA (qSOFA) is recommended for rapid assessment in non-ICU settings. Early recognition and treatment are crucial, with the Surviving Sepsis Campaign advocating for a 1-hour bundle of care to improve survival rates.
Medical Scores and Biomarkers: Clinical scores like APACHE-II, SOFA, and SAPS-2 are used in ICUs. Biomarkers such as CRP and Procalcitonin (PCT) are used for diagnosis and monitoring, though no single ideal biomarker has been identified. Blood cultures remain the gold standard for sepsis diagnosis, despite their limitations.
Presepsin as a Biomarker: Presepsin, a fragment derived from CD14, is a promising biomarker for sepsis. It has a shorter half-life than PCT, allowing for earlier and more effective management of sepsis. Presepsin levels increase during the immune response to infection, providing a potential tool for early diagnosis and monitoring.
Clinical Application: Presepsin can be used in various clinical settings, including ICU and ER, to support sepsis diagnosis. It is particularly useful in cases where traditional markers may be influenced by other factors such as burns or trauma.
Conclusion: The document emphasizes the importance of early diagnosis and treatment of sepsis to reduce mortality. Presepsin offers a valuable addition to the current diagnostic tools, providing a rapid and reliable biomarker for sepsis management.
Introduction to Presepsin: Presepsin is a fragment of the CD14 protein, produced during the immune response to bacterial infection. It is metabolized by the kidneys and excreted in urine. Its biological activity remains unknown, but it is a promising biomarker for sepsis diagnosis.
Measurement and Analysis: Presepsin levels can be measured using the PATHFAST™ analyzer, which provides results in less than 17 minutes from a small blood sample. The assay is precise and unaffected by common interferences like bilirubin and hemoglobin. Stability of samples varies with storage conditions, with whole blood stable for 4 hours at room temperature and plasma stable for up to a year when frozen.
Clinical Studies and Reference Values: Studies have established reference ranges for Presepsin in healthy individuals and its diagnostic cut-off values for sepsis. A cut-off of 600 pg/ml is used to differentiate bacterial from non-bacterial infections, with high sensitivity and specificity. Presepsin levels are less influenced by non-infectious inflammatory conditions compared to other markers like CRP and PCT.
Diagnostic and Prognostic Use: Presepsin is effective in early sepsis detection and risk stratification. It shows a rapid response to infection onset and correlates with patient outcomes during treatment. High levels indicate a higher risk of severe sepsis and mortality, making it a valuable tool for monitoring and prognosis in septic patients.
Conclusion: Presepsin is a reliable biomarker for sepsis diagnosis and management, offering advantages in early detection and monitoring of treatment efficacy. It provides critical information for risk assessment and decision-making in clinical settings.
Biomarker Analysis: In a multicentric study in Japan, Presepsin and other biomarkers were analyzed in sepsis patients. Presepsin levels remained elevated in patients with unfavorable outcomes, unlike other biomarkers that declined over time. This trend was particularly evident in patients receiving antimicrobial treatment.
Presepsin and Organ Dysfunction: Presepsin concentration correlates with the severity of sepsis and organ dysfunctions. It is metabolized through the kidneys, and its levels are affected by kidney failure. Different cut-off values are suggested for patients with chronic kidney disease and acute kidney injury.
Pathogen Specificity: Presepsin levels do not significantly differ between Gram-positive and Gram-negative bacterial infections. However, they may vary in pneumonia patients and are useful in differentiating active pulmonary tuberculosis from bacterial pneumonia.
Presepsin in Fungal Infections: Presepsin, along with Procalcitonin, can be used in diagnostic algorithms for invasive fungal infections. Elevated Presepsin levels correlate with increased SOFA scores in fungal bloodstream infections.
Clinical Applications: Presepsin is used in various clinical settings, including emergency, ICU, and hematology. It is particularly useful in febrile neutropenia and perioperative risk assessment, showing specificity for bacterial infections.
Conclusion: Presepsin is a valuable biomarker for diagnosing and assessing the severity of sepsis and other infections. It provides better discrimination than several other biomarkers and is a strong predictor of postoperative mortality in cardiac surgery patients.
Presepsin in Sepsis and Infections: Presepsin levels were found to be significantly elevated in patients with positive blood cultures and those who died from sepsis. The biomarker's levels decreased to threshold levels after antibiotic therapy in some cases. Presepsin was also useful in predicting 30-day mortality in pneumonia patients and distinguishing between bacterial and non-bacterial infections.
Diagnostic Performance: ROC analysis showed Presepsin's high sensitivity and specificity in predicting mortality and infection severity. It was compared with other markers like leukocytes and procalcitonin, showing superior diagnostic accuracy in many cases.
Presepsin in Neonatal Sepsis: Studies on neonates indicated that Presepsin is a reliable marker for early and late-onset sepsis, with specific cut-off values enhancing diagnostic accuracy. Meta-analyses confirmed its superior performance compared to CRP and PCT.
Other Applications: Presepsin has been studied in conditions like acute pancreatitis, myocardial infarction, and systemic lupus erythematosus, showing potential as a marker for inflammation and infection severity.
Conclusion: Presepsin is a promising biomarker for diagnosing and predicting the severity of infections, particularly sepsis. Its rapid measurement and high predictive values make it suitable for emergency settings. However, it should be used in conjunction with other diagnostic methods for accurate clinical decision-making.
See more

Catalog excerpts

ATHFAST™  PRESEPSIN – The Sepsis Biomarker Brochure-1

LIFE SAVING PRESEPSIN – The Sepsis Biomarker A short monograph

 Open the catalog to page 1
ATHFAST™  PRESEPSIN – The Sepsis Biomarker Brochure-3

more than $24 billion each year. The average cost per hospital stay for sepsis is $18,400, double the average cost per stay compared to all other conditions (4) Moreover, it is estimated that 3 million newborns and 1.2 million children suffer from sepsis globally every year (5). Three out of ten deaths due to neonatal sepsis are thought to be caused by resistant pathogens (6). Furthermore, one in ten deaths associated with pregnancy and childbirth is due to maternal sepsis with over 95% of deaths occurring in low- and middle-income countries (7). Totally, one million newborn deaths are associated...

 Open the catalog to page 3
ATHFAST™  PRESEPSIN – The Sepsis Biomarker Brochure-4

The 1-hour bundle consists of the measurement of lactate and the obtaining of blood cultures prior to the administration of antibiotics, broad-spectrum antibiotics, or the application of intravenous fluids and vasopressors. A rapid and reliable biomarker at the point of care for the detection of sepsis which is applicable directly in the ICU or ER can support the diagnosis of sepsis (15). Management of sepsis is a complicated clinical challenge requiring early recognition and management of infection, hemodynamic complications and other organ dysfunctions. The Surviving Sepsis Campaign (SSC) is...

 Open the catalog to page 4
ATHFAST™  PRESEPSIN – The Sepsis Biomarker Brochure-5

Medical scores and biomarkers for sepsis C-reactive protein (CRP), an acute phase protein increased at inflammatory states, is routinely used in patients with suspected infection. CRP however will be elevated for reasons other than bacterial infections such as burns, severe trauma and autoimmune diseases. Since formation of CRP is triggered by cytokines it will rise late (18). Assicot et al. reported first in 1993 that Procalcitonin (PCT) specifically increased in bacterial infection (19). PCT becomes essential for diagnosis of sepsis and for guiding their therapy and monitoring (20). In 2016,...

 Open the catalog to page 5
ATHFAST™  PRESEPSIN – The Sepsis Biomarker Brochure-6

Fig. 6: Schematic production of Presepsin What is Presepsin? In addition to the phagocytosis- and receptor model, several hypotheses are proposed in terms of Presepsin production because of the findings that Presepsin was produced even in patients with a very low number of white blood cells (WBC). Presepsin is metabolized through the kidneys and excreted with the urine (36). So far, the biological activity of Presepsin remains unknown. sCD14-ST is a 13k Da fragment derived from cleavage of CD14, a glycoprotein of 55 kDa anchored to the membrane of monocytes, macrophages and polymorphic neutrophils....

 Open the catalog to page 6
ATHFAST™  PRESEPSIN – The Sepsis Biomarker Brochure-7

Tab.3: Stability of blood samples Measurement of Presepsin In addition to Presepsin, the PATHFAST™ reagent menu offers several other STAT assays which can be used in sepsis diagnosis such as D-Dimer, NT-proBNP, hs-cTnI, CK-MB and hsCRP. All assays are provided in economical precalibrated unit-use cartridges. Up to six samples can be tested in parallel in one single run. Whole blood samples should be measured within 4 hours after collection. Plasma can be stored in the refrigerator for 3 days or may be frozen. The stability of whole blood and plasma is shown in Tab. 3. Complete Blood Count (CBC)...

 Open the catalog to page 7
ATHFAST™  PRESEPSIN – The Sepsis Biomarker Brochure-8

How to interpret Presepsin values? No significant differences between males and females were shown. Also, no influence by age was shown (37). Several studies described higher reference ranges of neonates than those for adults (see neonatal section). The accuracy of PATHFAST TM Presepsin was evaluated by Endo et al. in 2012. The cut off value of Presepsin for discrimination of bacterial and nonbacterial infectious diseases was determined to be 600 pg/ml, with clinical sensitivity and specificity of 87.8% and 81.4%, respectively. The area under the receiver ope- Okamura et al. reported the Presepsin...

 Open the catalog to page 8
ATHFAST™  PRESEPSIN – The Sepsis Biomarker Brochure-9

Tab. 5: Diagnosis of sepsis by Presepsin In clinical studies performed in Peru and Germany, cut off values were established. For healthy individuals the normal values of Presepsin are below 200 pg/mL. A Presepsin cut off value of 622 pg/ml excludes 30 day mortality by a Negative Predictive Value (NPV) of 98.5% (28). Based on the Presepsin values measured in the study patients with different disease severity degrees (SIRS, sepsis, severe sepsis or septic shock) and the close relationship between Presepsin and outcome decision thresholds for risk stratification could be established (Tab. 5; 22,...

 Open the catalog to page 9
ATHFAST™  PRESEPSIN – The Sepsis Biomarker Brochure-10

Specificity and sensitivity of Presepsin Fig. 7: Behavior of sepsis biomarker in a colon perforation patient Septic shock Operation One of the Presepsin advantages is the quick response against the onset of sepsis. A case study at Iwate Medical University compared the sepsis biomarkers Presepsin, PCT and CRP after a colon perforation with septic shock. Presepsin showed a high concentration level spontaneously at the infectious event and decreased in parallel with the APACHE II score. On the other hand, IL-6, CRP and Procalcitonin elevated one day after the onset of disease (Fig. 7). Presepsin...

 Open the catalog to page 10
ATHFAST™  PRESEPSIN – The Sepsis Biomarker Brochure-11

Fig. 9: Case report of sepsis biomarker in a burn patient SIRS 1600 positive blood culture Presepsin (in orange) and other markers in post-traumatic patients following a serious burn were considered. It is well-known that Presepsin values does not change after the trauma and there is an early increase in the values of Presepsin by day 2 following the occurrence of a bacterial infection confirmed by a positive blood culture of day 5. Effectiveness of anti-biotic treatment is shown at day 13 (Fig. 9, 24). Presepsin (pg/ml) In the case study by Shozushima et al., a 51-yearold patient was taken to...

 Open the catalog to page 11
ATHFAST™  PRESEPSIN – The Sepsis Biomarker Brochure-12

Fig. 11: Course of biomarkers over time Recommendation For final diagnosis, Presepsin results may support clinical findings but should not be used as a sole decision criteria for severity of organ damage. For ICU patients, a baseline cut off for Presepsin of approximately 1,000 pg/ml may be used which may increase with progression of disease and severity of organ failure. A clear difference in the development of Presepsin and PCT values during the course of treatment could be demonstrated with sepsis patients who got antimicrobial treatment after diagnosis of sepsis. Presepsin showed a clear...

 Open the catalog to page 12

All PHC Europe catalogs and technical brochures

  1. ULT Brochure

    52  Pages

  2. VIP Brochure

    16  Pages

  3. MPR-1014R-PE

    2  Pages

  4. MPR-N450FH-PE

    2  Pages

Archived catalogs

  1. MLS

    2  Pages

  2. MIR-162/262

    2  Pages

  3. MIR-H163-H263

    2  Pages

  4. MDF-U731M-PE

    2  Pages

  5. MDF-U5412-PE

    2  Pages

  6. MDF-U3386S-PE

    2  Pages

  7. MDF-U4186S-PE

    2  Pages

  8. MDF-U5386S-PE

    2  Pages

  9. MDF-U700VX-PE

    2  Pages

  10. MDF-U500VX-PE

    2  Pages

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.